All the Active Ingredient Drugs
Arexvy
GSK
Arexvy
Respiratory Syncytial Virus (RSV) vaccine. Respiratory Syncytial Virus recombinant glycoprotein F antigen 120 mcg/ 0.5 ml. 1/10 X Powder and susp. for IM inject. to obtain 0.5 ml dose
To be admin. as a single dose of 0.5 mL.
The need for revaccination has not been established.
Active immunisation for the prevention of lower respir. tract dis. (LRTD) caused by respir. syncytial virus in adults> 60 and adults 50 through 59 years of age who are at incr. risk for RSV dis.
C/I: Hypersens.
